What turns an AI pathology tool into a companion diagnostic? - Drug Discovery News
In oncology drug development, producing an AI model that predicts a patient's molecular profile from a digitized tissue image is now achievable.
Drug Discovery News 5
Covers: HealthcareMilitary & Defense
AI for blood-brain barrier permeability prediction: Methods and CNS drug design implications
Researchers at the Johns Hopkins Kimmel Cancer Center have developed an innovative liquid biopsy test that uses AI to detect early liver fibrosis and ...
FDA's action plan for AI in drug development: What scientists need to know
... an AI model that supports a drug or biologic claim should not assume a device-style PCCP is available to them today. Practical implications. For a ...
AI liquid biopsy offers early detection of liver disease | Drug Discovery News
Researchers at the Johns Hopkins Kimmel Cancer Center have developed an innovative liquid biopsy test that uses AI to detect early liver fibrosis and ...
CAR T cells: The last line of defense against childhood leukemia - Drug Discovery News
By comparison, an AI model that extracts biomarker signatures directly from routine pathology images could serve as a rapid pre-screening tool ...